The Nanomed Zone – EVO-NANO article
EVO-NANO was recently invited by a fellow website, The Nanomed Zone, to pen an opinion piece on the COVID-19 outbreak and the potential role nanomedicines can play in novel pandemics. …
EVO-NANO was recently invited by a fellow website, The Nanomed Zone, to pen an opinion piece on the COVID-19 outbreak and the potential role nanomedicines can play in novel pandemics. …
https://www.sciencedirect.com/science/article/pii/S2352914820301714 A team of members from the University of the West of England and the University of Novi Sad have come out with a paper in Informatics in Medicine Unlocked …
Our research partners at ProChimia have recently been involved in a breakthrough paper where nanoparticles have selectively killed cancer cells in vitro without using any toxic anti-cancer agents. The paper, …
Over the 29th to the 31st of January, the 2nd International Conference on Nanomaterials Applied to Life Sciences 2020 took place in Madrid, Spain. This conference was organized by our …
Click to read the full press release on the VHIR website Our EVO-NANO colleagues at the Vall d’Hebron Institut de Recerca have recently published work in connection with our project …
Monday the 18th marked the start of our two-day meeting in the lovely (if freezing cold) city of Brussels, Belgium. The EVO-NANO team met at the UK Research Office on …
Tuesday’s meeting at the EU Commission was a long day of presentations to a panel of four expert monitors, as well as our EU Project Officer. We assembled in the …
As a top figure at Vall d’Hebron Research Institute (VHIR) Dr. Simó Schwartz Jr. recently attended the Health Horizons: Future Healthcare Forum. While there, he acted as part of a …
First of all, could you please introduce yourselves to the readers? I’m sure they would like to get to know the people behind this project. I am a Professor of …
First of all, could you please introduce yourselves to the readers? I’m sure they would like to get to know the people behind this project. Hello, my name is Piotr …
